These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37479893)

  • 1. Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.
    Fan H; Wang F; Zeng A; Murison A; Tomczak K; Hao D; Jelloul FZ; Wang B; Barrodia P; Liang S; Chen K; Wang L; Zhao Z; Rai K; Jain AK; Dick J; Daver N; Futreal A; Abbas HA
    Commun Biol; 2023 Jul; 6(1):765. PubMed ID: 37479893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
    Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
    J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arms-race against resistance: leukemic stem cells and lineage plasticity.
    Waclawiczek A; Leppä AM; Renders S; Trumpp A
    Mol Oncol; 2024 Mar; 18(3):475-478. PubMed ID: 38375990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy.
    Ngo S; Oxley EP; Ghisi M; Garwood MM; McKenzie MD; Mitchell HL; Kanellakis P; Susanto O; Hickey MJ; Perkins AC; Kile BT; Dickins RA
    Nat Commun; 2021 Nov; 12(1):6546. PubMed ID: 34764270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
    Wong TN; Ramsingh G; Young AL; Miller CA; Touma W; Welch JS; Lamprecht TL; Shen D; Hundal J; Fulton RS; Heath S; Baty JD; Klco JM; Ding L; Mardis ER; Westervelt P; DiPersio JF; Walter MJ; Graubert TA; Ley TJ; Druley T; Link DC; Wilson RK
    Nature; 2015 Feb; 518(7540):552-555. PubMed ID: 25487151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
    Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
    Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.
    Corces MR; Buenrostro JD; Wu B; Greenside PG; Chan SM; Koenig JL; Snyder MP; Pritchard JK; Kundaje A; Greenleaf WJ; Majeti R; Chang HY
    Nat Genet; 2016 Oct; 48(10):1193-203. PubMed ID: 27526324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal single-cell atlas of treatment response in pediatric AML.
    Lambo S; Trinh DL; Ries RE; Jin D; Setiadi A; Ng M; Leblanc VG; Loken MR; Brodersen LE; Dai F; Pardo LM; Ma X; Vercauteren SM; Meshinchi S; Marra MA
    Cancer Cell; 2023 Dec; 41(12):2117-2135.e12. PubMed ID: 37977148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilic Realgar Nanocrystals Prolong the Survival of Refractory Acute Myeloid Leukemia Mice Through Inducing Multi-Lineage Differentiation and Apoptosis.
    Wang T; Zhang X; Jia M; Yang A; Liu J; Wen T; Meng J; Xu H
    Int J Nanomedicine; 2022; 17():2191-2202. PubMed ID: 35599749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
    Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
    Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity.
    van Galen P; Hovestadt V; Wadsworth Ii MH; Hughes TK; Griffin GK; Battaglia S; Verga JA; Stephansky J; Pastika TJ; Lombardi Story J; Pinkus GS; Pozdnyakova O; Galinsky I; Stone RM; Graubert TA; Shalek AK; Aster JC; Lane AA; Bernstein BE
    Cell; 2019 Mar; 176(6):1265-1281.e24. PubMed ID: 30827681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.
    Nilsson T; Waraky A; Östlund A; Li S; Staffas A; Asp J; Fogelstrand L; Abrahamsson J; Palmqvist L
    Int J Cancer; 2022 Sep; 151(5):770-782. PubMed ID: 35583991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
    Lee JH; Salci KR; Reid JC; Orlando L; Tanasijevic B; Shapovalova Z; Bhatia M
    Stem Cells; 2017 Sep; 35(9):2095-2102. PubMed ID: 28758276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic, genotypic, and functional characterization of normal and acute myeloid leukemia-derived marrow endothelial cells.
    Pizzo RJ; Azadniv M; Guo N; Acklin J; Lacagnina K; Coppage M; Liesveld JL
    Exp Hematol; 2016 May; 44(5):378-89. PubMed ID: 26851308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
    Guan Y; Gerhard B; Hogge DE
    Blood; 2003 Apr; 101(8):3142-9. PubMed ID: 12468427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
    Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
    IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.